Volume 9, Number 9—September 2003
Research
Aggregated Antibiograms and Monitoring of Drug-Resistant Streptococcus pneumoniae
Table 1
Site | Antibiogram | ABCs | |||||||
---|---|---|---|---|---|---|---|---|---|
No. laboratoriesa | Nonsusceptible isolates | Total no. isolates tested | % nonsusceptible | No. laboratories | Nonsusceptible isolates | Total no. isolates tested | % nonsusceptible | Difference in % nonsusceptible (antibiograms vs. ABCs) | |
Connecticut | 16 | 168 | 845 | 19.9 | 32 | 113 | 624 | 18.1 | 1.8 |
California | 9 | 107 | 577 | 18.5 | 10 | 30 | 184 | 16.3 | 2.2 |
Oregon | 9 | 115 | 550 | 20.9 | 15 | 32 | 178 | 18.0 | 2.9 |
Tennessee | 10 | 432 | 1,037 | 41.7 | 31 | 169 | 440 | 38.4 | 3.3 |
Maryland | 10 | 171 | 886 | 19.3 | 27 | 85 | 557 | 15.3 | 4.0 |
Georgia | 14 | 505 | 1,291 | 39.1 | 39 | 292 | 850 | 34.4 | 4.7 |
New York | 9 | 85 | 383 | 22.2 | 20 | 10 | 69 | 14.5 | 7.7 |
Minnesota | 19 | 315 | 1,037 | 30.4 | 25 | 95 | 435 | 21.8 | 8.6 |
Total | 96 | 1,898 | 6,606 | 28.7 | 199 | 826 | 3,337 | 24.8 | Median: 3.65 |
aOnly laboratories whose antibiograms covered the calendar year in question (1997 for all sites except NY [1998]) were compared to ABCs.
Page created: January 03, 2011
Page updated: January 03, 2011
Page reviewed: January 03, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.